,i #aae? ,,congress #a/ ,session ,h4 ,r4 #bjbf ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,april #f1 #bjag,mr4 ,gu?rie introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to improve pati5t access to em]g+ m$ication !rapies by cl>ify+ ! scope ( p]mitt$ heal? c>e economic & sci5tific in=mation communications betwe5 bioph>maceutical manufactur]s & population heal? decision mak]s4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,ph>maceutical ,in=mation ,ex*ange ,act4 #b4 ,facilitat+ ex*ange ( in=mation prior to approval ,section #ejb7;a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb7;a77 is am5d$-- 7#a7 by r$esignat+ subp>agraph 7#b7 z subp>agraph 7#c72 7#b7 by ins]t+ aft] subp>agraph 7#a7 ! foll[+3 7#b7 ,heal? c>e economic in=mation or sci5tific in=mation provid$ to a payor1 =mul>y committee1 or o!r simil> entity ) k & exp]tise 9 ! area ( heal? c>e economic analysis c>ry+ out its responsibilities = ! selection ( drugs = cov]age1 reimbursem5t1 or o!r population-bas$ heal? c>e managem5t1 %all n be consid]$ false or mislead+ or any o!r =m ( misbr&+ "u ?is p>agraph1 or a violation ( section #eje ( ?is ,act or section #cea ( ! ,public ,heal? ,s]vice ,act1 or o!rwise prohibit$ pre-approval promotion ( a drug1 if x is bas$ on compet5t & reliable sci5tific evid5ce & relates to an inve/igational new drug or an inve/igational use ( an approv$ drug4 ,9 ord] = in=mation relat+ to an inve/igational use ( an approv$ drug to be provid$ pursuant to ?is subp>agraph1 !re mu/ h be5 submitt$ to ! ,secret>y a supplem5tal application = approval ( su* use1 or ! /udy or /udies ne$$ to support ! submission ( a supplem5tal application = su* use mu/ h be5 complet$ ) ! int5tion t a supplem5tal application w be submitt$ to ! ,secret>y = approval ( ! use4 ,= purposes ( ?is subp>agraph1 sci5tific in=mation includes cl9ical & pre-cl9ical data & results relat+ to an unapprov$ drug !rapy1 or drug indication1 or o!r condition ( use be+ inve/igat$ or develop$4 2 & 7#c7 9 subp>agraph 7#c71 z r$esignat$-- 7,a7 by /rik+ 7,a72 & 7,b7 by /rik+ clause 7,b74